ANXA2 and ovarian carcinoma: ANXA2 is a tumour‐associated protein and acts as an oncogene to potentiate cancer progression including ovarian cancer, hepatoma and breast cancer.25, 26 In addition, the ANX family of proteins are associated with both chemotherapy and radiotherapy resistance.